image
KalVista Pharmaceuticals, Inc. KALV
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 11.42
-3.02 %
$ 568 M
Market Cap
-3.15
P/E
Price Target Average
98.48%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
26.09%
Net Income Estimate
27.85%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets KalVista Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for KALV of $22.7 , with forecasts ranging from a low of $20 to a high of $28 .
KALV Lowest Price Target Wall Street Target
20 USD 75.13%
KALV Average Price Target Wall Street Target
22.7 USD 98.48%
KALV Highest Price Target Wall Street Target
28 USD 145.18%
Price
Max Price Target
Min Price Target
Average Price Target
3030252520201515101055Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart KALV

image
$400.0m$400.0m$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020162016201820182019201920202020202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart KALV

image
$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)20162016201820182019201920202020202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart KALV

image
$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)20162016201820182019201920202020202420242025202520262026202720272028202820292029